{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:32:30Z","timestamp":1789435950985,"version":"build-2803163510"},"reference-count":60,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["HO-19-19968"],"award-info":[{"award-number":["HO-19-19968"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2021,1,1]]},"DOI":"10.1080\/13696998.2021.1941065","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T13:31:19Z","timestamp":1623418279000},"page":"874-882","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Cost-effectiveness analysis of anti\u2013IL-5 therapies of severe eosinophilic asthma in Spain"],"prefix":"10.1080","volume":"24","author":[{"given":"Francisco Javier","family":"Gonz\u00e1lez-Barcala","sequence":"first","affiliation":[{"name":"Hospital Cl\u00ednico Universitario de Santiago de Compostela, Santiago de Compostela, Spain"},{"name":"Respiratory Medicine, Universidad de Santiago de Compostela, Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mu\u00f1oz-Gall","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Hospital Universitari Vall d\u2019Hebron, Barcelona, Spain"},{"name":"CIBER of Respiratory Diseases (CIBERes), Madrid, Spain"},{"name":"Cell Biology, Physiology, and Immunology, Universidad Aut\u00f3noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Mariscal","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibing","family":"Yang","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Collegeville, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijs","family":"van de Wetering","sequence":"additional","affiliation":[{"name":"Pharmerit International, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Izquierdo-Alonso","sequence":"additional","affiliation":[{"name":"Medicine and Specialities Department, Universidad de Alcal\u00e1 (Alcal\u00e1 de Henares, Madrid), Hospital Universitario Guadalajara, Guadalajara, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30293-X"},{"key":"CIT0002","volume-title":"Global strategy for asthma management and prevention","author":"Global Initiative for Asthma","year":"2020"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2004.00526.x"},{"key":"CIT0004","volume-title":"A comprenhensive approach","author":"Global surveillance, prevention and control of chronic respiratory diseases.","year":"2007"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2018.1499035"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00202013"},{"key":"CIT0007","first-page":"e201703025","volume":"91","author":"Puig-Junoy J","year":"2017","journal-title":"Rev Esp Salud Publica"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2017.00067"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2019.1595966"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091375"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.08.031"},{"key":"CIT0012","volume-title":". Pocket guide for asthma management and prevention for adults and children older than 5 years old. A pocket guide for health professional updated 2019","author":"Global Initiative for Asthma","year":"2019"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00634-2017"},{"key":"CIT0014","unstructured":"European Medicines Agency. European Medicines Agency. Assessment report on extension(s) of marketing authorisation. Nucala. Procedure No. EMEA\/H\/C\/003860\/X\/0018. [Internet]. 2019. Available from: https:\/\/bit.ly\/37aRrJh. 2015."},{"key":"CIT0015","unstructured":"European Medicines Agency. Cinqaero: EPAR \u2013 product information. 2016."},{"key":"CIT0016","unstructured":"European Medicines Agency. Fasenra: EPAR \u2013 product information. 2018."},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.05.001"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12853"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1415"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0742-y"},{"key":"CIT0021","unstructured":"Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica. GEMA 5.0. Gu\u00eda espa\u00f1ola para el manejo del asma. 2020."},{"key":"CIT0022","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios M de S. Informe de posicionamiento terap\u00e9utico de benralizumab (Fasenra\u00ae) como tratamiento adicional en el asma grave no controlada eosinof\u00edlica [Internet]. 2019. Available from: https:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/informesPublicos\/docs\/IPT-benralizumab-Fasenra-asma_EPOC.pdf?x74012."},{"key":"CIT0023","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios M de S. Informe de posicionamiento terap\u00e9utico de reslizumab (Cinqaero\u00ae) como tratamiento adicional en el asma eosinof\u00edlica grave no controlada [Internet]. 2018. Available from: https:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/informesPublicos\/docs\/IPT-reslizumab-Cinqaero-asma_EPOC.pdf?x42633."},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1080\/20018525.2018.1536097"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.12.009"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0658-x"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-010-0244-4"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/S0213-9111(02)71933-X"},{"key":"CIT0030","unstructured":"National Institute for Health and Care Excellence. Mepolizumab for treating severe refractory eosinophilic asthma. Technology appraisal guidance [TA431]. 2017."},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2019.1674330"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403290"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403291"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv098"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.03.006"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.008914"},{"key":"CIT0038","unstructured":"Instituto Nacional de Estad\u00edstica (INE). Population mortality tables for Spain by year, province, sex, age, and functions. 2018."},{"key":"CIT0039","unstructured":"Base de Datos de Medicamentos. Consejo General de Colegios Oficiales de Farmac\u00e9uticos [WWW Document]. n.d."},{"key":"CIT0040","unstructured":"Ministerio de Sanidad C y BSG de E. Registro de Actividad de Atenci\u00f3n Especializada, Conjunto M\u00ednimo B\u00e1sico de Datos [WWW Document]. [cited 2020 Aug 4]. Available from: https:\/\/pestadistico.inteligenciadegestion.mscbs.es\/publicoSNS\/comun\/ArbolNodos.aspx?idNodo=23606"},{"key":"CIT0041","unstructured":"Gisbert R, Brosa M. Health costs and cost-effectiveness ratios database: eSalud. Barcelona: Oblikue Consulting, S.L. 2007."},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.avdiab.2013.07.007"},{"key":"CIT0043","unstructured":"ANEXO I Ficha T\u00e9cnica o Resumen de las Caracter\u00edsticas del producto, Nucala. FT_1151043001. European Medicines Agency."},{"key":"CIT0044","unstructured":"ANEXO I Ficha T\u00e9cnica o Resumen de las Caracter\u00edsticas del producto, Fasenra. FT_1171252001. European Medicines Agency."},{"key":"CIT0045","unstructured":"ANEXO I Ficha T\u00e9cnica o resumen de las caracter\u00edsticas del producto, Cinqaero. FT_1161125001. European Medicines Agency."},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2020.1719118"},{"key":"CIT0047","unstructured":"SIRIUS Statistical Report, Data on file. n.d."},{"key":"CIT0048","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention. 2015."},{"key":"CIT0049","first-page":"CD002308","volume":"12","author":"Edmonds M","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2010.09.011"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30125-X"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.3132\/pcrj.2007.00002"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X11401031"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.3111\/13696990701605235"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00550.x"},{"key":"CIT0056","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the economic evaluation of health care programmes","author":"Drummond MF","year":"2005","edition":"3"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1787\/4dd50c09-en"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S236609"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S114576"},{"key":"CIT0060","unstructured":"European Medicines Agency. Assessment report on extension(s) of marketing authorisation. Nucala. Procedure No. EMEA\/H\/C\/003860\/X\/0018; 2019."}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2021.1941065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T17:22:33Z","timestamp":1725211353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2021.1941065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,1]]}},"alternative-id":["10.1080\/13696998.2021.1941065"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2021.1941065","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-02-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}